Market open
Bausch + Lomb/$BLCO
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Bausch + Lomb
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Ticker
$BLCO
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Vaughan, Canada
Employees
13,300
Website
Bausch + Lomb Metrics
BasicAdvanced
$6.1B
-
-$1.05
0.46
-
Price and volume
Market cap
$6.1B
Beta
0.46
52-week high
$21.69
52-week low
$13.16
Average daily volume
611K
Financial strength
Current ratio
1.57
Quick ratio
0.722
Long term debt to equity
69.044
Total debt to equity
69.494
Interest coverage (TTM)
0.47%
Management effectiveness
Return on assets (TTM)
0.55%
Return on equity (TTM)
-5.23%
Valuation
Price to revenue (TTM)
1.29
Price to book
0.92
Price to tangible book (TTM)
-4.4
Price to free cash flow (TTM)
-104.17
Growth
Revenue change (TTM)
18.01%
Earnings per share change (TTM)
77.18%
3-year revenue growth (CAGR)
8.10%
3-year earnings per share growth (CAGR)
66.43%
Bausch + Lomb News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Bausch + Lomb stock?
Bausch + Lomb (BLCO) has a market cap of $6.1B as of January 27, 2025.
What is the P/E ratio for Bausch + Lomb stock?
The price to earnings (P/E) ratio for Bausch + Lomb (BLCO) stock is 0 as of January 27, 2025.
Does Bausch + Lomb stock pay dividends?
No, Bausch + Lomb (BLCO) stock does not pay dividends to its shareholders as of January 27, 2025.
When is the next Bausch + Lomb dividend payment date?
Bausch + Lomb (BLCO) stock does not pay dividends to its shareholders.
What is the beta indicator for Bausch + Lomb?
Bausch + Lomb (BLCO) has a beta rating of 0.46. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.